Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Koomen

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
Nature Communications|April 19, 2017
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphomaXiaohong Zhao, Tint Lwin, Ariosto Silva, et al.
BMC Medicine|September 24, 2023
Diagnostic and societal impact of implementing the syncope guidelines of the European Society of Cardiology (SYNERGY study)M Ghariq, W B van den Hout, O M Dekkers, et al.
The Journal of Clinical Investigation|September 28, 2018
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomasYuan Ren, Chengfeng Bi, Xiaohong Zhao, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2020
Managing a Large-Scale Multiomics Project: A Team Science Case Study in ProteogenomicsPaul A Stewart, Eric A Welsh, Bin Fang, et al.
Cancer Research|September 13, 2023
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple MyelomaKaren L Burger, Mario R Fernandez, Mark B Meads, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironmentHayley D Ackerman, Vanessa Y Rubio, Andrew J Davis, et al.
Nature Medicine|August 13, 2021
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trialBenjamin C Creelan, Chao Wang, Jamie K Teer, et al.
Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.
Nature Communications|August 10, 2019
Proteogenomic landscape of squamous cell lung cancerPaul A Stewart, Eric A Welsh, Robbert J C Slebos, et al.
Blood|December 9, 2024
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomesCiara L Freeman, Jerald Noble, Meghan Menges, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Nature Communications|April 19, 2017
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphomaXiaohong Zhao, Tint Lwin, Ariosto Silva, et al.
BMC Medicine|September 24, 2023
Diagnostic and societal impact of implementing the syncope guidelines of the European Society of Cardiology (SYNERGY study)M Ghariq, W B van den Hout, O M Dekkers, et al.
The Journal of Clinical Investigation|September 28, 2018
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomasYuan Ren, Chengfeng Bi, Xiaohong Zhao, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2020
Managing a Large-Scale Multiomics Project: A Team Science Case Study in ProteogenomicsPaul A Stewart, Eric A Welsh, Bin Fang, et al.
Cancer Research|September 13, 2023
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple MyelomaKaren L Burger, Mario R Fernandez, Mark B Meads, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironmentHayley D Ackerman, Vanessa Y Rubio, Andrew J Davis, et al.
Nature Medicine|August 13, 2021
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trialBenjamin C Creelan, Chao Wang, Jamie K Teer, et al.
Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.
Nature Communications|August 10, 2019
Proteogenomic landscape of squamous cell lung cancerPaul A Stewart, Eric A Welsh, Robbert J C Slebos, et al.
Blood|December 9, 2024
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomesCiara L Freeman, Jerald Noble, Meghan Menges, et al.
Pageof 23